Ciprofloxacin

Product NDC
25021-192
11-digit product format
250210192
Labeler code
25021
Product ID
25021-192_4f039d85-dab5-4f6e-8a0f-087a4c47b089
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ciprofloxacin
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
Sagent Pharmaceuticals
Application
ANDA078252
Marketing category
ANDA
Marketing start
2022-12-15
Substance
CIPROFLOXACIN
Active strength
2 mg/mL
Pharmacologic classes
Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
5E8K9I0O4UCIPROFLOXACIN85721-33-1CIPROFLOXACIN

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
25021-192-822502101928224 POUCH in 1 CARTON (25021-192-82) / 1 BAG in 1 POUCH / 100 mL in 1 BAG24 pouch2022-12-15NoNoHistorical
25021-192-872502101928724 POUCH in 1 CARTON (25021-192-87) / 1 BAG in 1 POUCH / 200 mL in 1 BAG24 pouch2022-12-15NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
CiprofloxacinSagent Pharmaceuticals2024-09-27HUMAN PRESCRIPTION DRUG LABEL3